Affordable Access

Publisher Website

The effect of a triple therapy on maternal anti-Ro/SS-A levels associated to fetal cardiac manifestations.

Authors
Type
Published Article
Journal
Autoimmunity Reviews
1568-9972
Publisher
Elsevier
Publication Date
Volume
14
Issue
5
Pages
423–428
Identifiers
DOI: 10.1016/j.autrev.2015.01.005
PMID: 25599954
Source
Medline
Keywords
  • Anti-Ro/Ss-A Antibodies
  • Congenital Heart Block
  • Intravenous Immunoglobulins
  • Neonatal Lupus
  • Sjögren Syndrome

Abstract

A triple therapy combining plasmapheresis, IVIG and glucocorticoids may stop the natural evolution of the fetal cardiac affectation in positive anti-Ro/SS-A antibody patients. Further studies are needed in order to validate clinical applications of this treatment approach.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F